BARRY JAMES 4

Accession 0001062993-24-016173

CIK 0000012208other

View on SEC.gov Company Profile

Filed

Sep 3, 8:00 PM ET

Accepted

Sep 4, 8:24 PM ET

Size

30.8 KB

Accession

0001062993-24-016173

Insider Transaction Report

Form 4

Period: 2024-09-01

BIO-RAD LABORATORIES, INC.BIO BIOB

BARRY JAMES

EVP, President, LSG

Transactions

Exercise/Conversion
Restricted Stock Units
2024-09-01−250→ 752 total
Exercise: $0.00→ Bio-Rad A Common Stock (250 underlying)
Exercise/Conversion
Restricted Stock Units
2024-09-02−265→ 0 total
Exercise: $0.00→ Bio-Rad A Common Stock (265 underlying)
Exercise/Conversion
Restricted Stock Units
2024-09-03−217→ 0 total
Exercise: $0.00→ Bio-Rad A Common Stock (217 underlying)
Tax Payment
Bio-Rad A Common Stock
2024-09-01$337.32/sh−90$30,359→ 236.555 total
Exercise/Conversion
Bio-Rad A Common Stock
2024-09-01+173→ 409.555 total
Sale
Bio-Rad A Common Stock
2024-09-04$330.49/sh−623$205,898→ 146.555 total
Exercise/Conversion
Restricted Stock Units
2024-09-01−177→ 178 total
Exercise: $0.00→ Bio-Rad A Common Stock (177 underlying)
Exercise/Conversion
Bio-Rad A Common Stock
2024-09-02+265→ 725.555 total
Tax Payment
Bio-Rad A Common Stock
2024-09-02$337.32/sh−95$32,045→ 630.555 total
Exercise/Conversion
Bio-Rad A Common Stock
2024-09-01+250→ 326.555 total
Tax Payment
Bio-Rad A Common Stock
2024-09-03$334.31/sh−78$26,076→ 769.555 total
Exercise/Conversion
Restricted Stock Units
2024-09-01−173→ 348 total
Exercise: $0.00→ Bio-Rad A Common Stock (173 underlying)
Tax Payment
Bio-Rad A Common Stock
2024-09-01$337.32/sh−62$20,914→ 347.555 total
Exercise/Conversion
Bio-Rad A Common Stock
2024-09-01+177→ 524.555 total
Tax Payment
Bio-Rad A Common Stock
2024-09-01$337.32/sh−64$21,588→ 460.555 total
Exercise/Conversion
Bio-Rad A Common Stock
2024-09-03+217→ 847.555 total

Footnotes (9)

[F1]Shares of Class A common stock acquired on the vesting of restricted stock units.
[F2]Includes 45.6820 shares acquired under the Bio-Rad Employee Stock Purchase Plan on 06/30/2024.
[F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $330.40 to $330.63, inclusive. The reporting person undertakes to provide to Bio-Rad Laboratories, Inc., any security holder of Bio-Rad Laboratories, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
[F4]Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.
[F5]On September 1, 2023, the reporting person was granted 1,002 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.
[F6]On September 1, 2022, the reporting person was granted 694 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.
[F7]On September 1, 2021, the reporting person was granted 709 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.
[F8]On September 2, 2020, the reporting person was granted 1,059 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.
[F9]On September 3, 2019, the reporting person was granted 1,083 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date.

Documents

1 file

4
form4.xmlPrimary
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Issuer

BIO-RAD LABORATORIES, INC.

CIK 0000012208

→

Entity typeother

Related Parties

filerCIK 0002022345

Filing Metadata

Form type: 4
Filed: Sep 3, 8:00 PM ET
Accepted: Sep 4, 8:24 PM ET
Size: 30.8 KB

View on SEC.gov